Canaccord Genuity Maintains Buy on Axogen, Raises Price Target to $55

Benzinga · 3d ago
Canaccord Genuity analyst Caitlin Roberts maintains Axogen (NASDAQ:AXGN) with a Buy and raises the price target from $50 to $55.